Cargando…
B-cells Drive Response to PD-1 Blockade in Glioblastoma Upon Neutralization of TGFβ-mediated Immunosuppression
Immunotherapy has revolutionized cancer treatment but has yet to be translated into brain tumors. Studies in other solid tumors suggest a central role of B-cell immunity in driving immune-checkpoint-blockade efficacy. Using single-cell and single-nuclei transcriptomics of human glioblastoma and mela...
Autores principales: | Hou, David, Castro, Brandyn, Dapash, Mark, Zolp, Andrew, Katz, Joshua, Arrieta, Víctor, Biermann, Jana, Melms, Johannes, Kueckelhaus, Jan, Benotmane, Jasim, Youngblood, Mark, Rashidi, Aida, Billingham, Leah, Dmello, Crismita, Vazquez-Cervantes, Gustavo, Lopez-Rosas, Aurora, Han, Yu, Patel, Ronit, Chia, Tzu-yi, Sun, Lu, Prins, Robert, Izar, Benjamin, Heiland, Deiter Henrik, Zhang, Peng, Sonabend, Adam, Miska, Jason, Lesniak, Maciej, Zhao, Junfei, Lee-Chang, Catalina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882679/ https://www.ncbi.nlm.nih.gov/pubmed/36711497 http://dx.doi.org/10.21203/rs.3.rs-2399170/v1 |
Ejemplares similares
-
STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma
por: Zhang, Peng, et al.
Publicado: (2023) -
The Interplay between Glioblastoma and Its Microenvironment
por: Dapash, Mark, et al.
Publicado: (2021) -
Ultrasound-mediated blood–brain barrier opening increases cell-free DNA in a time-dependent manner
por: Zhang, Daniel Y, et al.
Publicado: (2021) -
Current Immunotherapeutic Strategies for the Treatment of Glioblastoma
por: Dapash, Mark, et al.
Publicado: (2021) -
Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade
por: Dmello, Crismita, et al.
Publicado: (2023)